Compare Fuji Finance Indonesia Tbk. (FUJI) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Fuji Finance Indonesia Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Fuji Finance Indonesia Tbk. trades at Rp246 (market cap 317.2B, 749.4K 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Fuji Finance Indonesia Tbk. is far larger — about 3× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| FUJI | SCPI | |
|---|---|---|
Market Cap | 317.2B | 104.4B |
Volume | 749.4K | — |
Lot | 7.49K | — |
Turnover | 185.25M | — |
Average Price | 247.19 | — |
Value | 185.25M | — |
Indicative Equilibrium Price | 246 | — |
Indicative Equilibrium Volume | 490 | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Fuji Finance Indonesia Tbk.
PT Fuji Finance Indonesia Tbk (Company) was established first with the name of PT Jaya FajarLeasing Pratama based on Notarial Deed of Kartini Muljadi S.H., No. 287 on September 211982, which was changed to Jaya Fuji Leasing Pratama on March 28, 1983, then on July 2018 the Company's name was changed to Fuji Finance Indonesia
Read more on FUJI →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
